- Patient is planning therapy with androgen signaling inhibitor (cohort A), immunotherapy (cohort B), chemotherapy (cohort C), or targeted therapy (cohort D). Therapeutic combinations are allowed and as treatment may fall into more than one category cohort assignment will be per PI discretion. Treatment must be planned to start within 28 days of baseline tumor biopsy.